Stay updated on IpilimumabNivolumabLeptoMetClinicalTrial

Sign up to get notified when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.
Latest website image capture
Clouds background image

Latest updates to the IpilimumabNivolumabLeptoMetClinicalTrial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for ipilimumab and nivolumab in leptomeningeal metastases is displayed, including eligibility criteria, treatment plan, outcomes, study dates, and supporting documents.
    Difference
    60%
    Check dated 2026-11-11T19:12:59.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T19:07:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces website updates and a transition from the term “Artificial Intelligence” to “Super Intelligence.” The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T21:52:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-14T22:06:25.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T22:15:23.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, replacing the study record content and attached documents with an error screen and a Home link. This indicates that the core information about the trial is currently inaccessible on the page.
    Difference
    20%
    Check dated 2026-09-23T21:51:51.000Z thumbnail image

Stay in the know with updates to IpilimumabNivolumabLeptoMetClinicalTrial

Enter your email address, and we'll notify you when there's something new on the IpilimumabNivolumabLeptoMetClinicalTrial page.